Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.
about
Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptorMycoplasma pneumoniae and its role in asthmaChlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?COPD exacerbations . 2: aetiologyMycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stressAcute exacerbations and respiratory failure in chronic obstructive pulmonary diseaseAtypical bacteria and macrolides in asthmaAssessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.Changes in the Levels of Interleukin-17 Between Atopic and Non-atopic Children with Mycoplasma pneumoniae Pneumonia.
P2860
Q28384844-1F942043-2CF6-4DCA-A1CD-637BC883215BQ34653507-E10A4008-63E5-4F59-A1DD-501246905F8FQ36165742-2F00B6E1-86DC-4C0E-84BC-EBA1BC168924Q36414253-F8C06F88-CC59-4958-A694-69378C35F49AQ36898472-9D92D332-A779-42A2-9A4E-AF36F9353E44Q37103705-5355EB76-0769-41F8-B024-F3D518D5DE23Q40518030-EDF7CE6F-991D-41F5-BE12-D597364AAD97Q40846338-8D8140B2-6CA9-4E1B-A971-A26ABDEA1B49Q51567540-22D01E2E-645A-4C5E-8422-48728A9A7E42
P2860
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acute Chlamydia pneumoniae and ...... a: therapeutic considerations.
@en
Acute Chlamydia pneumoniae and ...... a: therapeutic considerations.
@nl
type
label
Acute Chlamydia pneumoniae and ...... a: therapeutic considerations.
@en
Acute Chlamydia pneumoniae and ...... a: therapeutic considerations.
@nl
prefLabel
Acute Chlamydia pneumoniae and ...... a: therapeutic considerations.
@en
Acute Chlamydia pneumoniae and ...... a: therapeutic considerations.
@nl
P2093
P2860
P921
P356
P1476
Acute Chlamydia pneumoniae and ...... ma: therapeutic considerations
@en
P2093
Bulgheroni A
Crepaldi M
Mangiarotti P
Paschetto E
P2860
P356
10.1179/JOC.2004.16.1.70
P577
2004-02-01T00:00:00Z